Alibhlinftecunspadr Stock Price To Sales

TWYA Stock  EUR 11.70  0.70  5.65%   
ALIBHLINFTECUNSPADR fundamentals help investors to digest information that contributes to ALIBHLINFTECUNSPADR's financial success or failures. It also enables traders to predict the movement of ALIBHLINFTECUNSPADR Stock. The fundamental analysis module provides a way to measure ALIBHLINFTECUNSPADR's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ALIBHLINFTECUNSPADR stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

ALIBHLINFTECUNSPADR Company Price To Sales Analysis

ALIBHLINFTECUNSPADR's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

 = 

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition

Based on the latest financial disclosure, ALIBHLINFTECUNSPADR has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Pharmaceutical Retailers (which currently averages 0.0) industry. The price to sales for all Germany stocks is 100.0% higher than that of the company.

ALIBHLINFTECUNSPADR Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ALIBHLINFTECUNSPADR's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ALIBHLINFTECUNSPADR could also be used in its relative valuation, which is a method of valuing ALIBHLINFTECUNSPADR by comparing valuation metrics of similar companies.
ALIBHLINFTECUNSPADR is currently under evaluation in price to sales category among its peers.

ALIBHLINFTECUNSPADR Fundamentals

About ALIBHLINFTECUNSPADR Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ALIBHLINFTECUNSPADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ALIBHLINFTECUNSPADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ALIBHLINFTECUNSPADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in ALIBHLINFTECUNSPADR Stock

ALIBHLINFTECUNSPADR financial ratios help investors to determine whether ALIBHLINFTECUNSPADR Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALIBHLINFTECUNSPADR with respect to the benefits of owning ALIBHLINFTECUNSPADR security.